Celadon Pharmaceuticals Plc

LSE : CEL

Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.

Information

Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Type
Common Stock
Country
United Kingdom

Price

GBp 36.50

Symbol

CEL

Type

Common Stock

Previous Close

:

36.70

52 Week Range

:

20.00 - 135.00

Volume

:

73,291.00

Average Volume

:

151,202.00

High

:

37.70

Low

:

35.00

Change

:

-0.20

Percent change (%)

:

-0.54

Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...